Skip to main content
SpringerLink
Log in

Practical Recommendations for the Drug Treatment of Bacterial Infections of the Male Genital Tract Including Urethritis, Epididymitis and Prostatitis

  • Disease Management
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Bacterial infections of the male genital tract in young men (<35 years old) are primarily caused by sexually transmissible bacteria like Chlamydia trachomatis, Neisseria gonorrhoeae but also Mycoplasma or Haemophilus spp. In men aged over 35 years, Enterobacteriaceae are more frequently involved in urethritis, epididymitis and prostatitis. The traditional treatments suggested like tetracyclines or erythromycin are less effective since bacterial resistance is increasingly frequent, particularly in N. gonorrhoeae. Moreover, patient compliance with these drug treatments are frequently not well observed. New therapies including short term therapy with fluoroquinolones or azalides (e.g. azithromycin) are very effective and easy to use and thus eliminate any problem of compliance. However, we have to be vigilant for the emergence of resistant strains to these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Meria P, Janier M, Desgrandchamps F, et al. Sexually transmitted disease in men. Prog Urol 1996; 6(3): 447–54

    PubMed  CAS  Google Scholar 

  2. Centers for Disease Control. 1998 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1997; RR1: 47

    Google Scholar 

  3. Centers for Disease Control. Chlamydia trachomutis genital infections in United States:1995. MMWR Morb Mortal Wkly Rep 1997; 46(9): 193–7

    Google Scholar 

  4. Janier M, Lassau F, Casin I, et al. Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis 1995; 22(4): 244–52

    Article  PubMed  CAS  Google Scholar 

  5. Joly-Guillou ML, Judlin P, Lefévre JC, et al. Bactéries isolées en 1994–1995 au cours des infections gynécologiques hautes et des urethrites masculines: distribution et sensibilité aux antibiotiques. Presse Medicale 1996; 25(8): 342–8

    CAS  Google Scholar 

  6. Jensen JS, Orsum R, Dohn B, et al. Mycoplasma genitalium: a cause of male urethritis? Genitourin Med 1993; 69(4): 265–9

    PubMed  CAS  Google Scholar 

  7. Uno M, Deguchi T, Komeda H, et al. Prevalence of Mycoplasma genitalium in men with gonococcal urethritis. Int J STD AIDS 1996; 7(6): 443–4

    Article  PubMed  CAS  Google Scholar 

  8. Sharma S, Brousseau R, Kasatiya S. Detection and confirmation of Mycoplasma pneumoniae in urogenital specimens by PCR. J Clin Microbiol 1998; 36(1): 277–80

    PubMed  CAS  Google Scholar 

  9. Lefevre JC, Lepargneur JP, Bauriaud R, et al. Clinical and microbiologic features of urethritis in men in Toulouse, France. Sex Trans Dis 1991; 18(2): 76–9

    Article  CAS  Google Scholar 

  10. Vasquez F, Andres MT, Palacio V, et al. Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in genitourinary infections: a 4 years review. Enferm Infecc Microbiol Clin 1996; 14(3): 181–5

    Google Scholar 

  11. Bhuiyan B, Rahman M, Miah MRA, et al. Antimicrobial susceptibilities and plamid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin. J Clin Microbiol 1999; 37(4): 1130–6

    PubMed  CAS  Google Scholar 

  12. Van de Laar MJ, Van Duynhoven YT, Dessens M, et al. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the Netherlands 1977–1995. Genitourin Med 1997; 73: 510–7

    PubMed  Google Scholar 

  13. Ngeow YF, Ramachandran S, Cheong YM. Treatment of gonorrhea with sulbactam/ampicillin. Sex Transm Dis 1991; 18(3): 192–4

    Article  PubMed  CAS  Google Scholar 

  14. Jones RB, Van der Pol B, Jonhson RB. Susceptibility of Chlamydia trachomatis to trovafloxacin. J Antimicrob Chemother 1997; 39 (B Suppl.): 63–5

    Article  PubMed  CAS  Google Scholar 

  15. Moi H, Morel P, Gianotti B, et al. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men. J Antimicrob Chemother 1996; 37 (A Suppl.): 115–22

    Article  PubMed  CAS  Google Scholar 

  16. Philips I, Dimian C, Barlow D, et al. A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men. J Antimicrob Chemother 1996; 37 (A Suppl.): 123–34

    Article  Google Scholar 

  17. Ronald AR, Peeling RW. Chlamydial infections and quinolones. Eur J Clin Microbiol Infect Dis 1991; 10(4): 351–4

    Article  PubMed  CAS  Google Scholar 

  18. Jones RB. New treatments for Chlamydia trachomatis. Am J Obstet Gynecol 1991; 164(6): 1789–93

    PubMed  CAS  Google Scholar 

  19. Bogaerts J, Tello WM, Akingeneye J, et al. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoeae and decrease susceptibility to quinolones over time in Rwanda. Genitourin Med 1993; 69(3): 196–200

    PubMed  CAS  Google Scholar 

  20. Centers for Disease Control. Fluoroquinolones resistance in Neisseria gonorrhoeae: Colorado, Washington 1995. MMWR Morb Mortal Wkly Rep 1995; 44: 761–4

    Google Scholar 

  21. Gordon SM, Carlyn CJ, Doyle LJ, et al. The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med 1996; 125: 465–70

    PubMed  CAS  Google Scholar 

  22. Deguchi T, Saito I, Tanaka M, et al. Fluoroquinolone treatment failure in gonorrhoea: emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones. Sex Transm Dis 1997; 24(5): 247–50

    Article  PubMed  CAS  Google Scholar 

  23. Vila J, Olmos L, Ballesteros J, et al. Development of in-vivo resistance after quinolone treatment of gonococcal urethritis. J Antimicrob Chemother 1997; 39(6): 841

    Article  PubMed  CAS  Google Scholar 

  24. Kenny GE, Hooton TM, Roberts MC, et al. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agent Chemother 1989; 33(1): 103–7

    Article  CAS  Google Scholar 

  25. Nilsson S, Johannisson G, Lycke E. Treatment of complicated infections of the male genital tract, with emphasis on Chlamydia trachomatis. Scand J Infect Dis Suppl 1982; 32: 173–6

    PubMed  CAS  Google Scholar 

  26. Carlin EM, Barton SE. Azithromycin as the first-line treatment of non-gonococcal urethritis (NGU): a study of follow-up rates, contact attendance and patients treatment preference. Int J STD AIDS 1996; 7(3): 185–9

    Article  PubMed  CAS  Google Scholar 

  27. Lauharanta J, Saarinen K, Mustonen MT, et al. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males.J Antimicrob Chemother 1993; 31 (E Suppl.): 177–83

    Article  PubMed  Google Scholar 

  28. Lister PJ, Balechandran T, Ridgway GL, et al. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. J Antimicrob Chemother 1993; 31 (E Suppl.): 185–92

    Article  PubMed  Google Scholar 

  29. Thorpe EM, Stamm WE, Hook EW, et al. Chlamydial cervitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practices. Genitourin Med 1996; 72(2): 93–7

    PubMed  Google Scholar 

  30. Waugh MA. Azithromycin in sexually transmitted disease: an overview. Int J STD AIDS 1991; 49(2): 246–7

    Google Scholar 

  31. Wendel TD. 1-day azithromycin was as effective as 7-day doxycycline for non gonococcal urethritis syndrome in men. ACP J Club 1996; 125(3): 82

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Microbiology Department, Louis Mourier University Hospital, 178 rue des Renouillers, 192701, Colombes, France

    Marie-Laure Joly-Guillou & Serge Lasry

Authors
  1. Marie-Laure Joly-Guillou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serge Lasry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marie-Laure Joly-Guillou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joly-Guillou, ML., Lasry, S. Practical Recommendations for the Drug Treatment of Bacterial Infections of the Male Genital Tract Including Urethritis, Epididymitis and Prostatitis. Drugs 57, 743–750 (1999). https://doi.org/10.2165/00003495-199957050-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199957050-00007

Keywords

Search

Navigation